Ceridian HCM Holding Inc (NYSE:CDAY) Stock Position Lessened by Morgan Stanley

Morgan Stanley decreased its holdings in Ceridian HCM Holding Inc (NYSE:CDAY) by 17.7% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,641 shares of the company’s stock after selling 1,643 shares during the quarter. Morgan Stanley’s holdings in Ceridian HCM were worth $384,000 as of its most recent filing with the SEC.

Several other large investors have also added to or reduced their stakes in the company. OMERS ADMINISTRATION Corp lifted its holdings in shares of Ceridian HCM by 1.0% in the second quarter. OMERS ADMINISTRATION Corp now owns 21,100 shares of the company’s stock valued at $1,074,000 after buying an additional 200 shares during the period. Captrust Financial Advisors lifted its holdings in shares of Ceridian HCM by 7.8% during the second quarter. Captrust Financial Advisors now owns 4,408 shares of the company’s stock valued at $221,000 after purchasing an additional 318 shares during the last quarter. Bessemer Group Inc. lifted its holdings in shares of Ceridian HCM by 2.2% during the second quarter. Bessemer Group Inc. now owns 20,569 shares of the company’s stock valued at $1,032,000 after purchasing an additional 435 shares during the last quarter. Aperio Group LLC purchased a new stake in shares of Ceridian HCM during the second quarter valued at $25,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Ceridian HCM by 32.6% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,308 shares of the company’s stock valued at $116,000 after purchasing an additional 568 shares during the last quarter. 69.66% of the stock is owned by institutional investors.

NYSE:CDAY traded up $0.19 during trading hours on Tuesday, hitting $54.19. 1,131 shares of the company’s stock traded hands, compared to its average volume of 2,393,449. The firm has a market cap of $7.93 billion, a P/E ratio of -1,087.20 and a beta of 1.45. Ceridian HCM Holding Inc has a twelve month low of $31.39 and a twelve month high of $58.95. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.10 and a current ratio of 1.10. The stock’s fifty day moving average price is $48.48 and its two-hundred day moving average price is $50.86.

Ceridian HCM (NYSE:CDAY) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.04. The firm had revenue of $202.30 million for the quarter, compared to analyst estimates of $196.52 million. Ceridian HCM had a return on equity of 2.24% and a net margin of 11.34%. Ceridian HCM’s quarterly revenue was up 13.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.10 earnings per share. On average, equities research analysts predict that Ceridian HCM Holding Inc will post 0.35 earnings per share for the current year.

In other Ceridian HCM news, CEO David D. Ossip sold 500,000 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $56.00, for a total value of $28,000,000.00. Also, EVP Lisa M. Sterling sold 6,250 shares of the company’s stock in a transaction dated Wednesday, September 18th. The stock was sold at an average price of $52.01, for a total value of $325,062.50. Insiders have sold 7,006,250 shares of company stock worth $392,325,063 over the last three months. 26.90% of the stock is owned by insiders.

CDAY has been the subject of several analyst reports. Jefferies Financial Group raised Ceridian HCM from a “hold” rating to a “buy” rating and upped their target price for the company from $58.00 to $65.00 in a report on Monday, August 19th. ValuEngine downgraded Ceridian HCM from a “buy” rating to a “hold” rating in a report on Wednesday, September 4th. Canaccord Genuity set a $55.00 target price on Ceridian HCM and gave the company a “hold” rating in a report on Wednesday, July 31st. Barclays set a $52.00 target price on Ceridian HCM and gave the company a “hold” rating in a report on Friday, November 1st. Finally, Cantor Fitzgerald initiated coverage on Ceridian HCM in a report on Wednesday, September 11th. They set an “overweight” rating and a $65.00 target price for the company. Seven research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $57.15.

Ceridian HCM Company Profile

Ceridian HCM Holding Inc operates as a human capital management (HCM) software company in the United States and internationally. The company offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud platform, which offers scalable and straightforward payroll and HR solutions.

Recommended Story: Resistance Level

Institutional Ownership by Quarter for Ceridian HCM (NYSE:CDAY)

Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.